Drug details

Plegridy (peginterferon beta-1a injection for subcutaneous use)

type of Immunomodulators

Plegridy (peginterferon beta-1a) Autoinjector is an interferon beta-1a used to treat patients with relapsing forms of multiple sclerosis.

This drug may have the following side effects:

• fever,
• chills,
• headache,
• weakness,
• vomiting
• muscle or joint pain,
• nausea, and
• injection site reactions (redness, itching, pain, swelling, warmth, rash, bruising),
• flu-like illness,

The following drugs are related to Plegridy, either as a replacement or used together:

• Lemtrada (alemtuzumab injection for intravenous infusion)
• Ampyra (dalfampridine extended-release tablets)
• Aubagio (teriflunomide tablets)
• Avonex (interferon beta-1a)
• Lyvispah (baclofen oral granules)
• Fleqsuvy (baclofen oral suspension)
• Betaseron (interferon beta-1b)
• Mavenclad (cladribine tablets)
• Copaxone (glatiramer acetate)
• Zinbryta (daclizumab for injection)
• Tecfidera (dimethyl fumarate delayed release capsules)
• Vumerity (diroximel fumarate delayed-release capsules)
• Extavia (interferon beta-1b kit)
• Gilenya (fingolimod capsules)
• Tascenso ODT (fingolimod orally disintegrating tablets)
• Glatopa (glatiramer acetate injection)
• Rebif (interferon beta-1a)
• Kesimpta (ofatumumab injection)
• Mayzent (siponimod tablets)
• Novantrone (mitoxantrone for injection concentrate)
• Provigil (modafinil)
• Tysabri (natalizumab)
• Ocrevus (ocrelizumab injection)
• Zeposia (ozanimod capsules)
• Peg-Intron (peginterferon alfa-2b)
• Ponvory (ponesimod tablets)